Literature DB >> 1920744

Torsades de pointes occurring in association with terfenadine use.

D R Mathews, B McNutt, R Okerholm, M Flicker, G McBride.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1920744

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

Review 1.  Manufacturer's drug interaction and postmarketing adverse event data: what are appropriate uses?

Authors:  W K Kraft; S A Waldman
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Examining the utilization and tolerability of the non-sedating antihistamine levocetirizine in England using prescription-event monitoring data.

Authors:  Deborah Layton; Vicki Osborne; Anna Gilchrist; Saad A W Shakir
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

3.  Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers.

Authors:  T Yang; C Prakash; D M Roden; D J Snyders
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

4.  Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.

Authors:  F J de Abajo; L A Rodríguez
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

5.  Torsades de pointes after terfenadine-itraconazole interaction.

Authors:  S Pohjola-Sintonen; M Viitasalo; L Toivonene; P Neuvonen
Journal:  BMJ       Date:  1993-01-16

Review 6.  Terfenadine. The first nonsedating antihistamine.

Authors:  H C Masheter
Journal:  Clin Rev Allergy       Date:  1993

7.  Examining the tolerability of the non-sedating antihistamine desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  Grapefruit juice-drug interactions.

Authors:  D G Bailey; J Malcolm; O Arnold; J D Spence
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

9.  Effect of concomitant administration of cimetidine and ranitidine on the pharmacokinetics and electrocardiographic effects of terfenadine.

Authors:  P K Honig; D C Wortham; K Zamani; D P Conner; J C Mullin; L R Cantilena
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia.

Authors:  S Pohjola-Sintonen; M Viitasalo; L Toivonen; P Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.